Arvinas, Inc. (ARVN)
NASDAQ: ARVN · IEX Real-Time Price · USD
24.85
-1.13 (-4.35%)
At close: Jul 2, 2024, 4:00 PM
24.50
-0.35 (-1.41%)
After-hours: Jul 2, 2024, 7:30 PM EDT
Arvinas Market Cap
Arvinas has a market cap or net worth of $1.70 billion as of July 2, 2024. Its market cap has increased by 25.03% in one year.
Market Cap
1.70B
Enterprise Value
528.33M
1-Year Change
25.03%
Ranking
Category
Stock Price
$24.85
Market Cap Chart
Since September 27, 2018, Arvinas's market cap has increased from $500.50M to $1.70B, an increase of 239.77%. That is a compound annual growth rate of 23.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 1.78B | -21.50% |
| Dec 29, 2023 | 2.26B | 24.38% |
| Dec 30, 2022 | 1.82B | -58.07% |
| Dec 31, 2021 | 4.34B | 26.11% |
| Dec 31, 2020 | 3.44B | 148.34% |
| Dec 31, 2019 | 1.39B | 233.58% |
| Dec 31, 2018 | 415.70M | -16.94% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeoGenomics | 1.75B |
| Immunocore Holdings | 1.74B |
| Zai Lab | 1.72B |
| Edgewise Therapeutics | 1.72B |
| Harmony Biosciences Holdings | 1.70B |
| National HealthCare | 1.70B |
| Galapagos NV | 1.67B |
| Veracyte | 1.63B |